Literature DB >> 12032912

Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus.

Po-Chou Liliang1, Cheng-Loong Liang, Wen-Neng Chang, Kang Lu, Cheng-Hsien Lu.   

Abstract

Between 1997 and 2000, 4 human immunodeficiency virus-negative patients in our institution had cryptococcal meningitis with uncontrollable intracranial hypertension. All 4 patients were treated with antifungal drugs as well as ventriculoperitoneal (VP) shunts for intracranial hypertension. Neurological deficits that were unresponsive to pharmacologic treatment were resolved by use of the VP shunt. Uncontrollable elevation of intracranial pressure associated with cryptococcal meningitis can be resolved by use of a VP shunt, even when imaging studies do not reveal hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032912     DOI: 10.1086/340525

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  [Early ventricle-atrium shunts for treating cryptococcal meningitis in children].

Authors:  Shi-Qi Guang; Fang He; Li-Wen Wu; Fei Yin; Jing Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

2.  Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.

Authors:  Robert A Larsen; Madeline Bauer; Ann M Thomas; J Richard Graybill
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

3.  Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

Authors:  John W Baddley; George R Thompson; Kristen O Riley; Mary K Moore; Stephen A Moser; Peter G Pappas
Journal:  Open Forum Infect Dis       Date:  2019-05-20       Impact factor: 3.835

4.  Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

Authors:  Caroline Charlier; Françoise Dromer; Christophe Lévêque; Loïc Chartier; Yves-Sébastien Cordoliani; Arnaud Fontanet; Odile Launay; Olivier Lortholary
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

5.  Predictors and long-term outcome of seizures in human immuno-deficiency virus (HIV)-negative cryptococcal meningitis.

Authors:  Chih-Wei Hung; Wen-Neng Chang; Chia-Te Kung; Nai-Wen Tsai; Hung-Chen Wang; Wei-Che Lin; Chi-Ren Huang; Chih-Cheng Huang; Wan-Chen Tsai; Hsueh-Wen Chang; Yu-Jih Su; Yu-Jun Lin; Ben-Chung Cheng; Ya-Ting Chang; Chih-Min Su; Cheng-Hsien Lu
Journal:  BMC Neurol       Date:  2014-10-13       Impact factor: 2.474

6.  Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis.

Authors:  Jia Liu; Zhuo-Lin Chen; Min Li; Chuan Chen; Huan Yi; Li Xu; Feng Tan; Fu-Hua Peng
Journal:  BMC Neurol       Date:  2018-05-01       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.